News Updates
More Articles
- The Pitfalls and Promise of Cell and Gene Therapy Development: A Time for Concerted Action
- “Not Just Checking a Box”: A Call to Rethink Patient Involvement in the EU
- From Cells to Animals and Back Again: The Shifting Landscape of Cancer Efficacy and Safety Models
- Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
- The Next AI Revolution: Computer System Validation
Clinical Safety & PV Community: Engage, Inform, Grow
The DIA Clinical Safety and Pharmacovigilance Community offers a collaborative environment in which to promote industry best practices, generate new ideas, and discuss the impacts of the changing regulatory environment as it relates to Clinical Safety and Pharmacovigilance (CSP).